Fast track (FDA)
US FDA designation for investigational drugs / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about FDA Fast Track Development Program?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
Fast track is a designation by the United States Food and Drug Administration (FDA) of an investigational drug for expedited review to facilitate development of drugs that treat a serious or life-threatening condition and fill an unmet medical need. Fast track designation must be requested by the drug company. The request can be initiated at any time during the drug development process. FDA will review the request and attempt to make a decision within sixty days.
This article needs additional citations for verification. (July 2022) |